Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Almquist

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The AAPS Journal|September 30, 2016
Tumor Static Concentration Curves in Combination TherapyTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 6, 2020
Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor ModulatorJoachim Almquist, Muhammad Waqas Sadiq, Ulf G Eriksson, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2019
Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agentsTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
Clinical Pharmacology and Therapeutics|May 23, 2026
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus NephritisJoachim Almquist, Yen Lin Chia, Raj Tummala, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2021
Exposure-response modeling improves selection of radiation and radiosensitizer combinationsTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
Journal of Pharmaceutical Sciences|July 3, 2014
Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acidSofia Tapani, Joachim Almquist, Jacob Leander, et al.
Clinical Pharmacokinetics|May 6, 2023
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of AnifrolumabWeifeng Tang, Raj Tummala, Joachim Almquist, et al.
The Journal of Biological Chemistry|March 15, 2014
Yeast AMP-activated protein kinase monitors glucose concentration changes and absolute glucose levelsLoubna Bendrioua, Maria Smedh, Joachim Almquist, et al.
Journal of Clinical Pharmacology|April 6, 2022
Nonlinear Population Pharmacokinetics of Anifrolumab in Healthy Volunteers and Patients With Systemic Lupus ErythematosusJoachim Almquist, Denison Kuruvilla, Tu Mai, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 23, 2017
Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatmentsRobert Andersson, Tobias Kroon, Joachim Almquist, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The AAPS Journal|September 30, 2016
Tumor Static Concentration Curves in Combination TherapyTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 6, 2020
Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor ModulatorJoachim Almquist, Muhammad Waqas Sadiq, Ulf G Eriksson, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2019
Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agentsTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
Clinical Pharmacology and Therapeutics|May 23, 2026
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus NephritisJoachim Almquist, Yen Lin Chia, Raj Tummala, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 8, 2021
Exposure-response modeling improves selection of radiation and radiosensitizer combinationsTim Cardilin, Joachim Almquist, Mats Jirstrand, et al.
Journal of Pharmaceutical Sciences|July 3, 2014
Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acidSofia Tapani, Joachim Almquist, Jacob Leander, et al.
Clinical Pharmacokinetics|May 6, 2023
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of AnifrolumabWeifeng Tang, Raj Tummala, Joachim Almquist, et al.
The Journal of Biological Chemistry|March 15, 2014
Yeast AMP-activated protein kinase monitors glucose concentration changes and absolute glucose levelsLoubna Bendrioua, Maria Smedh, Joachim Almquist, et al.
Journal of Clinical Pharmacology|April 6, 2022
Nonlinear Population Pharmacokinetics of Anifrolumab in Healthy Volunteers and Patients With Systemic Lupus ErythematosusJoachim Almquist, Denison Kuruvilla, Tu Mai, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 23, 2017
Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatmentsRobert Andersson, Tobias Kroon, Joachim Almquist, et al.
Pageof 3